Introduction: The SYS-CAPLIOX trial uses an implantable vascular access device (AVAS®) for repeated liver isolation intra-arterial oxaliplatin (LIOX) patients with inoperable colorectal cancer metastases (CRCLM). Similar to selective internal radiation therapy (SIRT), transarterial chemoembolization (TACE) and hepatic arterial infusion (HAI), the LIOX technique negates puncture has reduced surg...